Sandrine Andrieu

Summary

Country: France

Publications

  1. ncbi request reprint Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study
    Sandrine Andrieu
    Department of Internal Medicine and Clinical Gerontology, Acute Unit for Alzheimer s Patients, Toulouse, France
    J Gerontol A Biol Sci Med Sci 58:372-7. 2003
  2. ncbi request reprint Nutritional risk factors for institutional placement in Alzheimer's disease after one year follow-up
    S Andrieu
    Department of Internal Medicine and Clinical Gerontology, Alzheimer Center, 170 chemin de Casselardit, 31300 Toulouse, France
    J Nutr Health Aging 5:113-7. 2001
  3. ncbi request reprint Predictive factors of acute hospitalization in 134 patients with Alzheimer's disease: a one year prospective study
    Sandrine Andrieu
    Department of Internal Medicine and Clinical Gerontology, Acute Unit for Alzheimer s Patients, Toulouse, France
    Int J Geriatr Psychiatry 17:422-6. 2002
  4. ncbi request reprint New assessment of dependency in demented patients: impact on the quality of life in informal caregivers
    Sandrine Andrieu
    INSERM, U558, Laboratoire d Epidémiologie, Toulouse Cedex, France
    Psychiatry Clin Neurosci 61:234-42. 2007
  5. doi request reprint Methodological issues in primary prevention trials for neurodegenerative dementia
    Sandrine Andrieu
    INSERM U558, Toulouse, France
    J Alzheimers Dis 16:235-70. 2009
  6. ncbi request reprint Changes in informal care over one year for elderly persons with Alzheimer's disease
    S Andrieu
    Unité INSERM U558, Department of Epidemiology and Public Health, University of Toulouse, France
    J Nutr Health Aging 9:121-6. 2005
  7. ncbi request reprint [Burden experienced by informal caregivers assisting Alzheimer's patients in the REAL.FR study]
    S Andrieu
    INSERM U558, Laboratoire d Epidémiologie, Faculte de Medecine, 37, allées Jules Guesdes, 31073 Toulouse, France
    Rev Med Interne 24:351s-359s. 2003
  8. doi request reprint Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease
    Maria E Soto
    Alzheimer s Disease Research and Clinical Centre, Department of Geriatric Medicine, Gerontopole, Toulouse University Hospital, Toulouse, France
    J Alzheimers Dis 28:647-54. 2012
  9. doi request reprint Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease
    Maria E Soto
    Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
    Dement Geriatr Cogn Disord 26:109-16. 2008
  10. ncbi request reprint Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors
    Sophie Gillette-Guyonnet
    Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire La Grave Casselardit, 170 avenue de Casselardit, TSA40031, 31059 Toulouse Cedex 9, France
    J Gerontol A Biol Sci Med Sci 61:516-20. 2006

Detail Information

Publications63

  1. ncbi request reprint Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study
    Sandrine Andrieu
    Department of Internal Medicine and Clinical Gerontology, Acute Unit for Alzheimer s Patients, Toulouse, France
    J Gerontol A Biol Sci Med Sci 58:372-7. 2003
    ..The potential association between use of C4A treatments, in particular EGb 761 (standardized Ginkgo biloba extracts), and dementia of the Alzheimer type was investigated...
  2. ncbi request reprint Nutritional risk factors for institutional placement in Alzheimer's disease after one year follow-up
    S Andrieu
    Department of Internal Medicine and Clinical Gerontology, Alzheimer Center, 170 chemin de Casselardit, 31300 Toulouse, France
    J Nutr Health Aging 5:113-7. 2001
    ..006) were risk factors for institutional placement. Nutritional problems are reversible and patients with a low MNA score could benefit from a thorough geriatric assessment, in order to slow or prevent institutional placement...
  3. ncbi request reprint Predictive factors of acute hospitalization in 134 patients with Alzheimer's disease: a one year prospective study
    Sandrine Andrieu
    Department of Internal Medicine and Clinical Gerontology, Acute Unit for Alzheimer s Patients, Toulouse, France
    Int J Geriatr Psychiatry 17:422-6. 2002
    ..To evaluate the frequency of and determine predictive factors for acute hospitalization in a prospective study of patients with Alzheimer's disease (AD)...
  4. ncbi request reprint New assessment of dependency in demented patients: impact on the quality of life in informal caregivers
    Sandrine Andrieu
    INSERM, U558, Laboratoire d Epidémiologie, Toulouse Cedex, France
    Psychiatry Clin Neurosci 61:234-42. 2007
    ..The consequences appeared both on personal feelings and on quality of life and financial involvement in management of the patient. Cognitive impairment appears to have more moderate repercussions in these areas...
  5. doi request reprint Methodological issues in primary prevention trials for neurodegenerative dementia
    Sandrine Andrieu
    INSERM U558, Toulouse, France
    J Alzheimers Dis 16:235-70. 2009
    ..Future trials must therefore carefully consider the target population, outcomes and duration of follow-up to be used, and should assess the problem of attrition...
  6. ncbi request reprint Changes in informal care over one year for elderly persons with Alzheimer's disease
    S Andrieu
    Unité INSERM U558, Department of Epidemiology and Public Health, University of Toulouse, France
    J Nutr Health Aging 9:121-6. 2005
    ..Informal caregivers play a major role in all types of assistance for elderly persons with Alzheimer's disease but few longitudinal studies reports change in this role over time...
  7. ncbi request reprint [Burden experienced by informal caregivers assisting Alzheimer's patients in the REAL.FR study]
    S Andrieu
    INSERM U558, Laboratoire d Epidémiologie, Faculte de Medecine, 37, allées Jules Guesdes, 31073 Toulouse, France
    Rev Med Interne 24:351s-359s. 2003
    ..Most AD patients are cared for at home by informal caregivers. The effect of different kind of stressors on caregivers has been referred to as caregiver burden...
  8. doi request reprint Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease
    Maria E Soto
    Alzheimer s Disease Research and Clinical Centre, Department of Geriatric Medicine, Gerontopole, Toulouse University Hospital, Toulouse, France
    J Alzheimers Dis 28:647-54. 2012
    ..50, 95% CI = 1.04-2.17). In conclusion, weight loss predicted RCD in this cohort. Whether the prevention of weight loss (by improving nutritional status) impacts cognitive decline remains an open question...
  9. doi request reprint Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease
    Maria E Soto
    Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
    Dement Geriatr Cogn Disord 26:109-16. 2008
    ..Given the poorer prognosis of Alzheimer's disease (AD) patients with rapid cognitive decline (RCD), there is a need for a clinical assessment tool to detect these patients...
  10. ncbi request reprint Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors
    Sophie Gillette-Guyonnet
    Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire La Grave Casselardit, 170 avenue de Casselardit, TSA40031, 31059 Toulouse Cedex 9, France
    J Gerontol A Biol Sci Med Sci 61:516-20. 2006
    ..This study aims to investigate the effect of CEIs on three clinically relevant domains (rapid cognitive decline, institutionalization, and weight loss) in patients with Alzheimer's disease...
  11. doi request reprint Long-term progression of Alzheimer's disease in patients under antidementia drugs
    Sophie Gillette-Guyonnet
    Department of Internal Medicine and Geriatrics, Purpan University Hospital, Gerontopole Toulouse University Hospital, France
    Alzheimers Dement 7:579-92. 2011
    ..Data regarding the long-term disease progression outside of therapeutic trials are lacking. We examined the effects of standard of care for AD patients on the prognosis of the disease in a real-life study over a 4-year period...
  12. doi request reprint Characteristics of Alzheimer's disease patients with a rapid weight loss during a six-year follow-up
    Olivier Guerin
    INSERM U558, Department of Internal Medicine and Clinical Gerontology, CHU de Toulouse, Universite Paul Sabatier, France
    Clin Nutr 28:141-6. 2009
    ..Weight loss in Alzheimer's disease (AD) may be either progressive or rapid, with different consequences. The aim of this study was to characterize massive weight loss (>or= 5 kg over 6 months) during a 6.5-year follow-up...
  13. ncbi request reprint A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort)
    Fati Nourhashemi
    CHU Toulouse, Hôpital Casselardit, Service de médecine interne et gérontologie clinique, Toulouse, France
    Int J Geriatr Psychiatry 23:460-5. 2008
    ..The primary objective of our study was to examine the evolution of AD in individuals with very mild AD (CDR 0.5) across a 2-year follow up...
  14. doi request reprint Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study
    Frederic Cortes
    Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan Casselardit, Toulouse, France
    Alzheimers Dement 4:22-9. 2008
    ..The aim of the present study was to describe the long-term evolution of Alzheimer's disease (AD) in a prospective cohort of patients under treatment with a close follow-up...
  15. ncbi request reprint Wandering behavior and Alzheimer disease. The REAL.FR prospective study
    Yves Rolland
    Service de Medecine Interne et de Gerontologie Clinique, Pavillon Junot, Hopital La Grave Casselardit, 170 avenue de Casselardit, Toulouse, France
    Alzheimer Dis Assoc Disord 21:31-8. 2007
    ..Risk for undernutrition and death are not increased in wanderers. Their higher risk of ADL disabilities and institutionalization are partly explained by their baseline characteristics...
  16. pmc Comparison of informal care time and costs in different age-related dementias: a review
    Nadège Costa
    UMR1027, INSERM, 31073 Toulouse, France
    Biomed Res Int 2013:852368. 2013
    ..Dementias cause a substantial burden on society and on families who provide informal care. This study aims to review the relevant papers to compare informal care time and costs in different dementias...
  17. doi request reprint An abnormal "one-leg balance" test predicts cognitive decline during Alzheimer's disease
    Yves Rolland
    INSERM, U558, Toulouse, France
    J Alzheimers Dis 16:525-31. 2009
    ..8 (0.3) points at two years (p < 0.001). An abnormal one-leg balance test is a marker of more advanced dementia and predicts a higher rate of cognitive decline...
  18. ncbi request reprint Special acute care unit for older adults with Alzheimer's disease
    Maria E Soto
    CHU Toulouse, Department of Geriatric Medicine, Toulouse, France
    Int J Geriatr Psychiatry 23:215-9. 2008
    ..To describe the cognitive, functional, and nutritional features of patients admitted to a Special Acute Care Unit (SACU) for elderly patients with Alzheimer's disease (AD)...
  19. doi request reprint Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force
    Bruno Vellas
    UMR1027 Inserm, Toulouse, France
    Alzheimers Dement 9:438-44. 2013
    ....
  20. doi request reprint Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort
    Christophe Arbus
    Paul Sabatier University, Department of Psychiatry and Medical Psychology, Purpan Casselardit Hospital, Toulouse, France
    Int Psychogeriatr 22:120-8. 2010
    ..The aim of this survey was to assess the prevalence of antidepressant use in AD and to identify the clinical factors associated with antidepressant prescription...
  21. doi request reprint Improving care of older adults with dementia: description of 6299 hospitalizations over 11 years in a special acute care unit
    Maria E Soto
    Department of Geriatric Medicine, Gérontopôle de Toulouse, Toulouse University Hospital, Toulouse, France
    J Am Med Dir Assoc 13:486.e1-6. 2012
    ..To describe hospitalizations in a Special Acute Care inpatient Unit for older adults with Alzheimer's disease (AD) and other related disorders...
  22. ncbi request reprint GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data
    Sandrine Andrieu
    INSERM, U558, F 31073, Toulouse, France
    Curr Alzheimer Res 5:406-15. 2008
    ..5% presented a CDR score of 0.5. This study will enable us to evaluate the efficacy of EGb761 in the prevention of AD, and to assess the usefulness of various baseline characteristics as predictors of conversion to AD in this population...
  23. doi request reprint Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR study
    Nicola Coley
    INSERM, U558, University of Toulouse III, Toulouse, France
    Neuroepidemiology 31:69-79. 2008
    ..Attrition, i.e. patient dropout, can threaten the validity of results in longitudinal studies. The aim of this study was to identify patient and caregiver factors predictive of attrition in a cohort of Alzheimer disease (AD) patients...
  24. doi request reprint Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study
    Virginie Gardette
    Department of Epidemiology and Public Health, Toulouse University Hospital, Université de Toulouse UPS, INSERM U558, Gerontopole, Toulouse, France
    CNS Drugs 24:431-42. 2010
    ..There is a lack of data concerning the optimal drug treatment duration and the reasons for discontinuation, particularly outside the clinical trial setting...
  25. ncbi request reprint Is there a relationship between fat-free soft tissue mass and low cognitive function? Results from a study of 7,105 women
    Fati Nourhashemi
    Department of Internal Medicine and Gerontology Clinic, CHU Purpan Casselardit, Toulouse, France
    J Am Geriatr Soc 50:1796-801. 2002
    ..To test the hypothesis that low fat-free soft tissue mass and cognitive impairment are independently associated...
  26. ncbi request reprint Risk factors for functional decline and institutionalisation among community-dwelling older adults with mild to severe Alzheimer's disease: one year of follow-up
    Maria E Soto
    Médicine Interne et Gériatrie, CHU Purpan Casselardit, Toulouse, Midi Pirinées, France
    Age Ageing 35:308-10. 2006
  27. doi request reprint Weight changes in Alzheimer's disease patients with increased aberrant motor behavior
    Marion Secher
    University of Toulouse III, F 31073, Toulouse, France Gerontopole, CMRR, F 31059, Toulouse, France
    Int J Geriatr Psychiatry 28:998-1004. 2013
    ..We investigated the impact of aberrant motor behavior (AMB) on weight changes in older adults with AD. The hypothesis that patients with AMB are more likely to lose weight than patients without AMB was assessed...
  28. doi request reprint Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial
    Bruno Vellas
    INSERM U1027, Toulouse, France
    Lancet Neurol 11:851-9. 2012
    ..We aimed to assess efficacy of long-term use of standardised ginkgo biloba extract for the reduction of incidence of Alzheimer's disease in elderly adults with memory complaints...
  29. doi request reprint Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort
    Gabor Abellan van Kan
    Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
    J Gerontol A Biol Sci Med Sci 67:425-32. 2012
    ..The aim of the study was to evaluate whether GS, TLM, and TFM were associated factors with an increased risk for subsequent dementia in community-dwelling older women...
  30. doi request reprint Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease
    Sophie Gillette-Guyonnet
    Gérontopôle de Toulouse, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France
    Alzheimers Dement 5:114-21. 2009
    ..The study also collects imaging and biological data that could be used in future AD prevention and treatment trials...
  31. ncbi request reprint Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: a prospective randomized study
    Sylvie Lauque
    Alzheimer Research and Clinical Center, Toulouse University Hospital, Toulouse, France
    J Am Geriatr Soc 52:1702-7. 2004
    ..To study the effects of oral nutritional supplements (OS) on body weight, body composition, nutritional status, and cognition in elderly patients with Alzheimer's disease (AD)...
  32. ncbi request reprint Body composition in French women 75+ years of age: the EPIDOS study
    Sophie Gillette-Guyonnet
    Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan Casselardit, 170 avenue de Casselardit, F 31300 Toulouse, France
    Mech Ageing Dev 124:311-6. 2003
    ..There are presently no published data on age-related changes in body composition in French individuals older than 65 or 80 years. This paper presents a cross-sectional study of 7518 community-residing French women older than 75 years...
  33. pmc Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study)
    Fati Nourhashemi
    Gerontopole, CMRR, Toulouse, France
    BMJ 340:c2466. 2010
    ..To test the effectiveness of a comprehensive specific care plan in decreasing the rate of functional decline in patients with mild to moderate Alzheimer's disease compared with usual care in memory clinics...
  34. pmc Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease
    Adeline Gallini
    INSERM, UMR1027, 31062, Toulouse, France
    Drugs Aging 30:439-45. 2013
    ..Previous studies have reported a lower use of analgesics in patients with Alzheimer's disease (AD) than in non-AD elderly. To date, no study has focused on persistent analgesic use in patients with mild-to-moderate AD...
  35. doi request reprint Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!
    Francois Montastruc
    Laboratoire de Pharmacologie Medicale et Clinique, Faculte de Medecine, Universite de Toulouse, 37 Allees Jules Guesde, 31000 Toulouse, France
    Eur J Clin Pharmacol 69:1589-97. 2013
    ..The aim of our study was to assess the prevalence of PIM in community-dwelling patients diagnosed with mild-to-moderate AD and identify the clinical factors associated with PIM prescriptions...
  36. doi request reprint Prevention trials in Alzheimer's disease: an EU-US task force report
    Bruno Vellas
    INSERM, U1027, F 31073, Toulouse, France
    Prog Neurobiol 95:594-600. 2011
    ....
  37. doi request reprint Cardiovascular disease risk factors and progression of Alzheimer's disease
    Gabor Abellan van Kan
    INSERM U558, Department of Geriatric Medicine, CHU Toulouse, Toulouse, France
    Dement Geriatr Cogn Disord 27:240-6. 2009
    ..To assess if cardiovascular disease risk factors (CVDRF) are predictive factors for poorer evolution of Alzheimer's disease (AD) patients in terms of cognitive decline...
  38. ncbi request reprint Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial
    Yves Rolland
    Internal Medicine Service and Gerontology Clinic, Hopital La Grave Casselardit, Toulouse, France
    J Am Geriatr Soc 55:158-65. 2007
    ....
  39. ncbi request reprint A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study
    Virginie Gardette
    Inserm UMR1027, 31073, Toulouse, France
    CNS Drugs 28:157-70. 2014
    ..There is no consensus on when and how to discontinue cholinesterase inhibitors (ChEI). Predictors of non-persistency of antidementia drugs have been poorly investigated, mostly during short-term periods and using administrative data...
  40. doi request reprint Endpoints for trials in Alzheimer's disease: a European task force consensus
    Bruno Vellas
    INSERM U558, Toulouse, France
    Lancet Neurol 7:436-50. 2008
    ..A clear and consensual definition of endpoints is crucial for the success of further clinical trials in the field and will allow comparison of data across studies...
  41. pmc A Self-Reported Screening Tool for Detecting Community-Dwelling Older Persons with Frailty Syndrome in the Absence of Mobility Disability: The FiND Questionnaire
    Matteo Cesari
    Institut du vieillissement, Gerontopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France Inserm UMR1027, Université de Toulouse III Paul Sabatier, Toulouse, France
    PLoS ONE 9:e101745. 2014
    ..Aim of this study is to verify the agreement of a novel self-reported questionnaire (the "Frail Non-Disabled" [FiND] instrument) designed for detecting non-mobility disabled frail older persons with results from reference tools...
  42. doi request reprint Psychotropic drug consumption at admission and discharge of nursing home residents
    Yves Rolland
    INSERM, Toulouse, France
    J Am Med Dir Assoc 13:407.e7-12. 2012
    ..To quantify transitions of residents into or out of nursing homes (NHs) and to describe psychotropic drug prescription at admission and discharge and with regard to dementia diagnosis...
  43. ncbi request reprint Disease modifying trials in Alzheimer's disease: perspectives for the future
    Bruno Vellas
    Gerontopole, CHU Toulouse, Department of Geriatric Medicine, Toulouse, France
    J Alzheimers Dis 15:289-301. 2008
    ....
  44. ncbi request reprint Cognitive function and caregiver burden: predictive factors for eating behaviour disorders in Alzheimer's disease
    Stéphanie Rivière
    Department of Internal Medicine and Clinical Gerontology, Hopital La Grave Casselardit, Toulouse, France
    Int J Geriatr Psychiatry 17:950-5. 2002
    ..These behaviours lead to weight loss and frequently to physicians using tube feeding. Little is known about factors correlated with feeding difficulties during AD...
  45. ncbi request reprint Cognitive impairment and composition of drinking water in women: findings of the EPIDOS Study
    Sophie Gillette-Guyonnet
    Service de médecine interne et gérontologie clinique, Hôpital Casselardit, Toulouse, France
    Am J Clin Nutr 81:897-902. 2005
    ..The concentration of aluminum or silica in drinking water may be a potential environmental risk factor for Alzheimer disease (AD)...
  46. doi request reprint Dementia prevention: methodological explanations for inconsistent results
    Nicola Coley
    INSERM unit 558, Toulouse, France
    Epidemiol Rev 30:35-66. 2008
    ..Because of the multifactorial origin of dementia, it appears that multidomain interventions could be a suitable candidate for preventive interventions, but designing such trials remains very challenging for researchers...
  47. ncbi request reprint Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity
    Virginie Gardette
    Universite de Toulouse III, France
    Curr Alzheimer Res 9:1106-16. 2012
    ..To date, antipsychotic risks outweigh their benefits in BPSD for which non-pharmacological approaches remain the first-line strategy and should be privileged...
  48. ncbi request reprint Disease-modifying trials in Alzheimer's disease: a European task force consensus
    Bruno Vellas
    Alzheimer Disease Research and Clinical Center, University of Toulouse, Toulouse, France
    Lancet Neurol 6:56-62. 2007
    ....
  49. pmc Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA study
    Caroline M Sanz
    UMR 1027, INSERM, University of Toulouse III, Toulouse, France
    Diabetes Care 36:1512-21. 2013
    ....
  50. doi request reprint AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials
    Bruno Vellas
    Department of Geriatrics, INSERM U558, Toulouse University Hospital Center, Toulouse, France
    Alzheimers Dement 7:e109-17. 2011
    ..This article highlights some of the challenges faced by investigators when conducting clinical trials in AD, and it also offers some recommendations aimed at overcoming these challenges...
  51. pmc Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings
    Adeline Gallini
    Universite Paul Sabatier, Toulouse III, Faculte de Medecine, Département d Epidémiologie, économie de la santé et santé publique, F 31073, Toulouse, France INSERM, UMR 1027 Epidémiologie et analyses en santé publique, F 31073, Toulouse, France CHU de Toulouse, Service d épidémiologie, F 31073, Toulouse, France Electronic address
    Eur Neuropsychopharmacol 24:95-104. 2014
    ..Meanwhile, use of SGAs continuously increased from 0.37% to 0.64%. Antipsychotic use decreased in the elderly between 2003 and 2011, especially in dementia. The timing of the decrease, however, did not coincide with safety warnings. ..
  52. pmc Methodological considerations in cost of illness studies on Alzheimer disease
    Nagede Costa
    Department of Medical Information, University Hospital of Toulouse, Toulouse, F 31059, France
    Health Econ Rev 2:18. 2012
    ..To increase its credibility, closer agreement among researchers on the methodological principles of cost studies would be desirable...
  53. doi request reprint Memory health clinics-a first step to prevention
    Bruno Vellas
    Department of Internal Medicine and Clinical Gerontology, Gerontopole, Toulouse Université Hospital, CHU La Grave Casselardit, Toulouse, France Inserm U 558, Toulouse, France
    Alzheimers Dement 4:S144-9. 2008
    ..Leon Thal suggested that this could have a much bigger impact than all the drugs we might ever hope to develop. The main objective of this article is to present the rationale for multi-domain preventive approaches...
  54. ncbi request reprint [Physical restraint in old people's homes. Evaluation of skills following specific training]
    Julie Biga
    Unite INSERM 558, Faculte de Medecine, Toulouse
    Presse Med 33:1169-73. 2004
    ....
  55. doi request reprint Early prediction of failure to lose weight after obesity surgery
    Patrick Ritz
    Department of Cardiovascular and Metabolic Diseases, CHU Toulouse, Toulouse, France
    Surg Obes Relat Dis 9:118-21. 2013
    ..Our objective was to report the criteria for an early prediction of the failure to lose enough weight in the setting of a private practice and an academic center of obesity surgery...
  56. ncbi request reprint The Multidomain Intervention to preveNt disability in ElDers (MINDED) project: rationale and study design of a pilot study
    Matteo Cesari
    Gerontopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France Inserm UMR1027, Université de Toulouse III Paul Sabatier, Toulouse, France Electronic address
    Contemp Clin Trials 38:145-54. 2014
    ....
  57. ncbi request reprint [Managing Alzheimer's disease: global care and support program]
    Fati Nourhashemi
    Hôpitaux de Toulouse P B Vellas, 31300 Toulouse
    Rev Prat 55:1903-11. 2005
    ..The primary care practitioner should provide information and education about current level of disease and should talk with the patient and family to establish treatment goals...
  58. ncbi request reprint [Epidemiology of dementia]
    Claudine Berr
    INSERM, U888, Universite Montpellier 1, Montpellier 34
    Presse Med 36:1431-41. 2007
    ..Data from well-conducted intervention studies are necessary to show whether better care for hypertension, diabetes, and dyslipidemia might decrease the incidence of dementia...
  59. ncbi request reprint Beyond the global score of the Zarit Burden Interview: useful dimensions for clinicians
    Joel Ankri
    Laboratoire Santé et Vieillissement, Université Versailles Saint Quentin, Paris, France
    Int J Geriatr Psychiatry 20:254-60. 2005
    ....
  60. ncbi request reprint Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease
    Catherine Helmer
    INSERM U593, Universite de Bordeaux 2, Bordeaux, France
    Dement Geriatr Cogn Disord 23:168-74. 2007
    ..To determine the predictive value of the 6-month evolution of the ADAS-cog score in initially mild to moderate Alzheimer's disease (AD) patients on the risk of death or severe dementia (MMSE <10) within 2 years...
  61. ncbi request reprint Colonization of the oral cavity by Candida species: risk factors in long-term geriatric care
    Anne M Grimoud
    Section of Odontology, Hotel Dieu Saint Jacques, University Hospital, 31052 Toulouse, France
    J Oral Sci 45:51-5. 2003
    ..Detecting which patients have been colonized, identifying the risk factors and applying preventive measures should reduce the probability of elderly people falling into the vicious circle of infection-malnutrition-immune-depression...
  62. ncbi request reprint Different modes of weight loss in Alzheimer disease: a prospective study of 395 patients
    Olivier Guerin
    Department of Gerontology, University Hospital, Nice, France
    Am J Clin Nutr 82:435-41. 2005
    ..Alzheimer disease is often accompanied and worsened by malnutrition. Patterns of weight loss can differ by the patients concerned and by the outcome and interventions required...
  63. ncbi request reprint Response to letter from Garcia and colleagues on cholinesterase inhibitors and Alzheimer's disease outcomes
    Sophie Gillette-Guyonnet
    J Gerontol A Biol Sci Med Sci 62:679-80. 2007